about
Exploring factors associated with ART adherence and retention in care under Option B+ strategy in Malawi: A qualitative study.A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.The value of informal care in the context of option B+ in Malawi: a contingent valuation approachViral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.Follow-up and programmatic outcomes of HIV-exposed infants registered in a large HIV centre in Lilongwe, Malawi: 2012 - 2014.Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi.Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
P50
Q33821909-DBD4D543-3E75-453F-AE15-0D8437B333D5Q33868639-C4E59BD1-2FA6-440C-9936-28A5B73F60DAQ33883748-2D741316-3F41-4A1D-A8B2-151C3F4DB8C3Q35994342-B2FBE899-8A96-4711-BCFB-9FA46C766FABQ38789600-4313DE78-590E-46BB-AF9B-F99E31065363Q39301390-3DC2AC71-EC62-4247-81D7-668473922DD4Q42203348-8B083835-960E-412F-80F4-679DB3853837Q47548768-EFA98B32-891F-486E-BAA9-819915308CEC
P50
description
researcher ORCID ID = 0000-0003-3545-3117
@en
wetenschapper
@nl
name
Salem Gugsa
@ast
Salem Gugsa
@en
Salem Gugsa
@es
Salem Gugsa
@nl
type
label
Salem Gugsa
@ast
Salem Gugsa
@en
Salem Gugsa
@es
Salem Gugsa
@nl
prefLabel
Salem Gugsa
@ast
Salem Gugsa
@en
Salem Gugsa
@es
Salem Gugsa
@nl
P106
P31
P496
0000-0003-3545-3117